7 Monster Stock Market Predictions For The Week Of February 23

Published 02/24/2020, 04:10 AM
Updated 11/16/2024, 07:53 AM
US500
-
GOOGL
-
AAPL
-
GOOG
-

It will not be a busy week in terms of economic newsflow, but we will likely see a great amount of volatility. Markets will still be trying to figure out what the potential impact of the coronavirus is on the economy. But investors will get their first taste on Friday night when China will release its official manufacturing PMI.

S&P 500 (SPY)

The S&P 500 created a couple of reversal patterns, with two falling wedges, and a potential double bottom. We may get a better sense of things once the futures open, and Asia starts trading. There are several levels of support in the index at 3,316, and then 3,300, with a big gap fill down around 3,260.

S&P 500 Index

If the index should rise, and the reversal patterns prove to be correct, the index can increase to around 3,373.

Amazon (AMZN)

Amazon’s cup and handle pattern vanished rather quickly after falling through support at 2,134. It likely means that the shares retest support and the prior all-time highs of roughly 2,050.

Amazon Inc 240 Min Chart

Alphabet (GOOGL)

Alphabet (NASDAQ:GOOGL) broke support and is now likely to test support at $1,430.

Alphabet Inc 240 Min Chart

Apple (AAPL)

Apple (NASDAQ:AAPL) has been dropping, and now the RSI is trending lower, and it means that the stock is in a period of consolidation. The stock is at support at $311, and the next significant level of support comes around $308. If the uptrend breaks, we could see some further downside in the stock, potentially to the $290 region.

Apple Inc Daily Chart

Netflix (NFLX)

The RSI on NFLX continues to trend higher, and I think that means the stock continues higher, pushing towards $400.

Netflix Inc Daily Chart

Nvidia (NVDA)

I continue to believe that Nvidia will fall and fill the gap at $273.

NVIDIA Corp Daily Chart

Acadia (ACAD)

Acadia will report results on Wednesday, and I’m hoping to hear something about a pre-sNDA meeting with the FDA on Dementia-related psychosis. The RSI is now trending higher, and I think this one is heading back to the highs of around $51. I think Nuplazid has a chance of getting an approval for DRP before the end of 2020; I’m keeping my fingers crossed.

Acadia Pharma Inc Chart

Original Post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.